Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioprex Medical is a biotechnology company specializing in the development of innovative antibacterial coatings for medical devices to prevent hospital-acquired infections. A spin-off from the University of Groningen, the company utilizes a patented technology based on immobilized quaternary ammonium compounds (QACs) that are covalently anchored to device surfaces. This contact-killing mechanism effectively eliminates bacteria upon contact without leaching biocides into the patient's body, addressing the limitations of traditional antimicrobial coatings. The technology is designed for application on a wide range of indwelling devices, including catheters, infusions, and surgical implants. Currently in the preclinical stage, Bioprex Medical is focused on demonstrating the safety and efficacy of its three-layer coating system to improve patient outcomes and reduce healthcare costs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioprex.